Lund, Sweden

Hakan S Bergstrand

This inventor holds 2 USPTO granted patents. Top assignee: Aktiebolaget Astra. Active years: 1995.


% Patents Active = 100.0

Average Co-Inventor Count = 5.8

ph-index = 2

Forward Citations = 58(Granted Patents)


Location History:

  • Lund, SE (1995)
  • Bjarred, SE (1995)

Company Filing History:


Years Active: 1995

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Hakan S Bergstrand: Innovator in Pharmaceutical Science

Introduction

Hakan S Bergstrand is a notable inventor based in Lund, Sweden. He has made significant contributions to the field of pharmaceutical science, particularly in the development of treatments for immune system disorders. With a total of 2 patents, his work has the potential to impact many lives.

Latest Patents

Bergstrand's latest patents include innovative pharmaceutical preparations aimed at treating diseases caused by defects in the immune system. One of his patents focuses on the pharmacological use of certain cystine derivatives, which are crucial for developing effective treatments. Another patent details the creation of new crystalline organic salts of N,N'-diacetyl cystine, which possess immunomodulating effects. These patents outline processes for their preparation, pharmaceutical compositions containing them, and methods for their pharmacological use.

Career Highlights

Hakan S Bergstrand is associated with Aktiebolaget Astra, a prominent company in the pharmaceutical industry. His work at this organization has allowed him to collaborate with other talented professionals and contribute to groundbreaking research in immunology.

Collaborations

Bergstrand has worked alongside notable colleagues such as Carl-Magnus Alexander Andersson and Bengt Olof Sarnstrand. Their combined expertise has fostered an environment of innovation and discovery in the pharmaceutical field.

Conclusion

Hakan S Bergstrand's contributions to pharmaceutical science, particularly in the area of immune system treatments, highlight his role as an influential inventor. His patents and collaborations reflect a commitment to advancing medical science and improving patient outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…